Loading clinical trials...
Loading clinical trials...
An Early Feasibility Study to Explore a Novel Objective Pain Measurement Using a Wearable Biosensor and a Novel Mobile Platform in Patients With Endometriosis (OPINE)
Conditions
Locations
7
United States
Mayo Clinic
Phoenix, Arizona, United States
Mayo Clinic
Rochester, Minnesota, United States
National University Hospital
Singapore, Singapore
Singapore General Hospital
Singapore, Singapore
KK Women's and Children's Hospital
Singapore, Singapore
Taichung Veterans General Hospital
Taichung, Taiwan
Start Date
November 6, 2020
Primary Completion Date
October 28, 2021
Completion Date
February 22, 2022
Last Updated
May 19, 2022
NCT05951452
NCT06611501
NCT05726786
NCT07241637
NCT04567771
NCT07215130
Lead Sponsor
Biofourmis Singapore Pte Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions